Where to go to in chlamydia control? From infection control towards infectious disease control
Authors:
Open Access
- 27 May 2021
- journal article
- review article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 97 (7) , 501-506
Abstract
Objectives The clinical and public health relevance of widespread case finding by testing for asymptomatic chlamydia infections is under debate. We wanted to explore future directions for chlamydia control and generate insights that might guide for evidence-based strategies. In particular, we wanted to know the extent to which we should pursue testing for asymptomatic infections at both genital and extragenital sites. Methods We synthesised findings from published literature and from discussions among national and international chlamydia experts during an invitational workshop. We described changing perceptions in chlamydia control to inform the development of recommendations for future avenues for chlamydia control in the Netherlands. Results Despite implementing a range of interventions to control chlamydia, there is no practice-based evidence that population prevalence can be reduced by screening programmes or widespread opportunistic testing. There is limited evidence about the beneficial effect of testing on pelvic inflammatory disease prevention. The risk of tubal factor infertility resulting from chlamydia infection is low and evidence on the preventable fraction remains uncertain. Overdiagnosis and overtreatment with antibiotics for self-limiting and non-viable infections have contributed to antimicrobial resistance in other pathogens and may affect oral, anal and genital microbiota. These changing insights could affect the outcome of previous cost–effectiveness analysis. Conclusion The balance between benefits and harms of widespread testing to detect asymptomatic chlamydia infections is changing. The opinion of our expert group deviates from the existing paradigm of ‘test and treat’ and suggests that future strategies should reduce, rather than expand, the role of widespread testing for asymptomatic chlamydia infections.Keywords
This publication has 32 references indexed in Scilit:
- The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesisHealth Technology Assessment, 2016
- Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in the NetherlandsSexually Transmitted Infections, 2015
- Chlamydia Test Results Were Associated With Sexual Risk Behavior Change Among Participants of the Chlamydia Screening Implementation in the NetherlandsSexually Transmitted Diseases, 2015
- An Alternative Scenario to Explain Rectal Positivity in Chlamydia-Infected IndividualsClinical Infectious Diseases, 2015
- Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)The Lancet, 2013
- Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementationBMJ, 2012
- Protective Immunity toChlamydia trachomatisGenital Infection: Evidence from Human StudiesThe Journal of Infectious Diseases, 2010
- CCR5 Deficiency Is a Risk Factor for Early Clinical Manifestations of West Nile Virus Infection but not for Viral TransmissionThe Journal of Infectious Diseases, 2010
- How can chlamydia diagnoses increase when their complications are declining?Sexually Transmitted Infections, 2005
- The Natural Course ofChlamydia trachomatisInfection in Asymptomatic Colombian Women: A 5‐Year Follow‐Up StudyThe Journal of Infectious Diseases, 2005